Filing Details
- Accession Number:
- 0001127602-18-030504
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-17 16:15:28
- Reporting Period:
- 2018-10-15
- Accepted Time:
- 2018-10-17 16:15:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885590 | Bausch Health Companies Inc. | BHC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1681871 | Christina Ackermann | 400 Somerset Corporate Boulevard Bridgewater NJ 08807 | Evp And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, No Par Value | Disposition | 2018-10-15 | 15,404 | $24.83 | 55,998 | No | 4 | S | Direct | |
Common Stock, No Par Value | Disposition | 2018-10-16 | 4,542 | $25.50 | 51,456 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.